Renalytix PLC (RNLX)
0.5601
-0.10
(-15.77%)
USD |
NASDAQ |
May 15, 15:21
Renalytix 1 Year Total Returns (Daily): -69.91% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 14, 2024 | -69.91% |
| May 13, 2024 | -71.99% |
| May 10, 2024 | -74.61% |
| May 09, 2024 | -74.87% |
| May 08, 2024 | -74.36% |
| May 07, 2024 | -71.08% |
| May 06, 2024 | -71.13% |
| May 03, 2024 | -68.88% |
| May 02, 2024 | -67.00% |
| May 01, 2024 | -63.59% |
| April 30, 2024 | -70.76% |
| April 29, 2024 | -71.48% |
| April 26, 2024 | -73.24% |
| April 25, 2024 | -70.97% |
| April 24, 2024 | -72.11% |
| April 23, 2024 | -69.88% |
| April 22, 2024 | -67.85% |
| April 19, 2024 | -67.92% |
| April 18, 2024 | -67.83% |
| April 17, 2024 | -66.26% |
| April 16, 2024 | -66.75% |
| April 15, 2024 | -66.02% |
| April 12, 2024 | -62.95% |
| April 11, 2024 | -62.12% |
| April 10, 2024 | -64.87% |
| Date | Value |
|---|---|
| April 09, 2024 | -64.62% |
| April 08, 2024 | -66.62% |
| April 05, 2024 | -66.39% |
| April 04, 2024 | -66.66% |
| April 03, 2024 | -65.58% |
| April 02, 2024 | -64.88% |
| April 01, 2024 | -65.90% |
| March 28, 2024 | -60.37% |
| March 27, 2024 | -60.94% |
| March 26, 2024 | -57.31% |
| March 25, 2024 | -56.20% |
| March 22, 2024 | -49.14% |
| March 21, 2024 | -53.49% |
| March 20, 2024 | -56.67% |
| March 19, 2024 | -55.36% |
| March 18, 2024 | -53.57% |
| March 15, 2024 | -62.61% |
| March 14, 2024 | -61.78% |
| March 13, 2024 | -64.22% |
| March 12, 2024 | -61.15% |
| March 11, 2024 | -51.28% |
| March 08, 2024 | -61.62% |
| March 07, 2024 | -60.34% |
| March 06, 2024 | -61.86% |
| March 05, 2024 | -59.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.89%
Minimum
Oct 21 2022
149.1%
Maximum
Oct 21 2021
-38.50%
Average
-64.22%
Median
Mar 13 2024
1 Year Total Returns (Daily) Benchmarks
| TC BioPharm (Holdings) PLC | -92.53% |
| Ainos Inc | -71.11% |
| Biodexa Pharmaceuticals Plc | -94.26% |
| Aptorum Group Ltd | 34.11% |
| Adaptimmune Therapeutics PLC | -16.06% |